India gets low cost biosimilar of Remicade

[jiml]

A question regarding biosimilars are their any restrictions on where they can be sold?
What I mean is are we likely to see price wars or pressure on the other drugs to reduce prices?

My understanding is that they can only be sold in the country they are approved for, they have to go through the same tests as the original to be deemed suitable under that countries regulations.

So in India both will be available but Infimab will be offered as a cheaper alternative, but as it's not approved for use say in the UK then it will still be Remicade that UK residents will get.

So will the biosimilar companies go for approval in other countries or will they stay where approval is easier